Objectives We investigated the impact of the coronavirus disease 2019 (COVID-19) pandemic on tuberculosis (TB) management in the Republic of Korea (ROK).
Methods This retrospective cross-sectional study used nationwide ROK TB notification data (98,346 cases) from 2017 to 2020. The median time from the onset of TB symptoms to treatment initiation and the compliance rates with the required timing for notification and individual case investigations were measured and compared across periods and regions affected by the COVID-19 epidemic.
Results TB diagnosis during the COVID-19 pandemic was delayed. The median time to TB treatment initiation (25 days) in 2020 increased by 3 days compared to that of the previous 3 years (22 days) (p<0.0001). In the outbreak in Seoul, Incheon, and Gyeonggi province during August, the time to TB diagnosis was 4 days longer than in the previous 3 years (p=0.0303). In the outbreak in Daegu and Gyeongbuk province from February to March 2020, the compliance rate with the required timing for individual case investigations was 2.2%p points lower than in other areas in 2020 (p=0.0148). For public health centers, the rate was 13%p lower than in other areas (80.3% vs. 93.3%, p=0.0003).
Conclusion TB diagnoses during the COVID-19 pandemic in the ROK were delayed nationwide, especially for patients notified by public-private mix TB control hospitals. TB individual case investigations were delayed in regional COVID-19 outbreak areas (Daegu and Gyeongbuk province), especially in public health centers. Developing strategies to address this issue will be helpful for sustainable TB management during future outbreaks.
Citations
Citations to this article as recorded by
A Review of the Impact of Patent Medicine Vendors in Driving Community Tuberculosis Case Finding in the COVID-19 Pandemic in Nigeria Arinze Emmanuel Ajogwu, Onwubiko Iheanyichukwu Samuel, Nnanyelugo Longinus Ochike, Uzoma Chidinma Ajegbo, Chinedu Paschal Maduka Matrix Science Medica.2024; 8(2): 33. CrossRef
Tuberculosis: Republic of Korea, 2021 Jinsoo Min, Hyung Woo Kim, Ju Sang Kim Tuberculosis and Respiratory Diseases.2023; 86(1): 67. CrossRef
Prevalence and associated factors of diabetes mellitus among patients with tuberculosis in South Korea from 2011 to 2018: a nationwide cohort study Dawoon Jeong, Jeongha Mok, Doosoo Jeon, Hee-Yeon Kang, Hee Jin Kim, Hee-Sun Kim, Jeong Mi Seo, Hongjo Choi, Young Ae Kang BMJ Open.2023; 13(3): e069642. CrossRef
Increased Healthcare Delays in Tuberculosis Patients During the First Wave of COVID-19 Pandemic in Korea: A Nationwide Cross-Sectional Study Jinsoo Min, Yousang Ko, Hyung Woo Kim, Hyeon-Kyoung Koo, Jee Youn Oh, Yun-Jeong Jeong, Hyeon Hui Kang, Kwang Joo Park, Yong Il Hwang, Jin Woo Kim, Joong Hyun Ahn, Yangjin Jegal, Ji Young Kang, Sung-Soon Lee, Jae Seuk Park, Ju Sang Kim Journal of Korean Medical Science.2022;[Epub] CrossRef
Time trend prediction and spatial–temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014–2020 Wang Yun, Chen Huijuan, Liao Long, Lu Xiaolong, Zhang Aihua BMC Infectious Diseases.2022;[Epub] CrossRef
Real-world association of adherence with outcomes and economic burden in patients with tuberculosis from South Korea claims data Sun-Hong Kwon, Jin Hyun Nam, Hye-Lin Kim, Hae-Young Park, Jin-Won Kwon Frontiers in Pharmacology.2022;[Epub] CrossRef
The Impact of the COVID-19 Pandemic on Tuberculosis Case Notification and Treatment Outcomes in Eswatini Hloniphile Victory Masina, I-Feng Lin, Li-Yin Chien International Journal of Public Health.2022;[Epub] CrossRef
Trends in incidences of newly notified tuberculosis in Jeju Province, Korea, 2017-2021 Jinhee Kim, Nam-Hun Kang, Jong-Myon Bae Journal of Medicine and Life Science.2022; 19(3): 103. CrossRef